Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Other Clinical Trial
StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements
Status: Enrolling, Phase III
Updated: 12/31/1969
Universtiy of California - Irvine Health Regional Burn Center
mi
from
Orange, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of a CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 (Pembrolizumab) and of NKTR-214 in Combination With Anti-PD-L1 (Atezolizumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
New Brunswick
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Memoral Sloan Kettering Basking Ridge (Consent only)
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic Surgery
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre (Consent only)
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Aging Clinical Trial
Affordable Mobile Robots for the Elderly
Status: Enrolling
Updated: 12/31/1969
Mercy Living Independently for Elders (L.I.F.E) - West Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Stroke Clinical Trial
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 12/31/1969
Dell Seton Medical Center at The University of Texas
mi
from
Austin, TX
Click here to add this to my saved trials
Stroke Clinical Trial
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Health Presbyterian Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Stroke Clinical Trial
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 12/31/1969
Seton Medical Center Hays
mi
from
Kyle, TX
Click here to add this to my saved trials
Stroke Clinical Trial
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
Status: Enrolling, Phase III
Updated: 12/31/1969
Seton Medical Center Williamson
mi
from
Round Rock, TX
Click here to add this to my saved trials
Overweight and Obesity Clinical Trial
Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects With Prediabetes and With and Without Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
SAMCRC
mi
from
San Antonio, TX
Click here to add this to my saved trials
Methamphetamine Use Disorder Clinical Trial
Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
Status: Enrolling, Phase III
Updated: 12/31/1969
Behavioral Health Services (BHS) of Pickens County
mi
from
Pickens, SC
Click here to add this to my saved trials
Meningococcal Vaccine Clinical Trial
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to
Status: Enrolling, Phase III
Updated: 12/31/1969
Alabama Clinical Therapeutics, LLC / Birmingham Pediatric Associates
mi
from
Birmingham, AL
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Ochsner High Grove
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Nebraska Medicine-Village Pointe
mi
from
Omaha, NE
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Stanford Cancer Institute Palo Alto
mi
from
Palo Alto, CA
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health - Park Rapids
mi
from
Park Rapids, MN
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Delbert Day Cancer Institute at PCRMC
mi
from
Rolla, MO
Click here to add this to my saved trials
B Acute Lymphoblastic Leukemia Clinical Trial
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Siteman Cancer Center at Saint Peters Hospital
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Reproductive Clinical Trial
REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mesa Obstetricians and Gynecologist
mi
from
Mesa, AZ
Click here to add this to my saved trials
Patients With Advanced Solid Tumor or Lymphoma Clinical Trial
APG-115 in Patients With Advanced Solid Tumors or Lymphomas
Status: Enrolling, Phase I
Updated: 12/31/1969
START Midwest
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Rheumatology Clinical Trial
A Clinical Investigation of the Vanguard™ Complete Knee System
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Orthopedic Specialists
mi
from
Grapevine, TX
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Colorado - Aurora Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Indiana University (IU) Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Graft-versus-host Disease (GVHD) Clinical Trial
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Wake Forest Baptist Medical Center - Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
End Stage Renal Disease Clinical Trial
Clinical Evaluation of a Vascular Venous Anastomotic Connector
Status: Enrolling
Updated: 12/31/1969
Surgical Specialists of Charlotte
mi
from
Charlotte, NC
Click here to add this to my saved trials
Relapsed/Refractory Acute Lymphoblastic Leukemia Clinical Trial
An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ames, IA
Click here to add this to my saved trials
Relapsed/Refractory Acute Lymphoblastic Leukemia Clinical Trial
An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Relapsed/Refractory Acute Lymphoblastic Leukemia Clinical Trial
An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Relapsed/Refractory Acute Lymphoblastic Leukemia Clinical Trial
An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Relapsed/Refractory Acute Lymphoblastic Leukemia Clinical Trial
An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Oncology Clinical Trial
HeadStart4: Newly Diagnosed Children (
Status: Enrolling, Phase IV
Updated: 12/31/1969
Nemours Center for Cancer and Blood Disorders
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
HeadStart4: Newly Diagnosed Children (
Status: Enrolling, Phase IV
Updated: 12/31/1969
Masonic Children's Hospital/University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Breast Cancer Clinical Trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Oncology - Allen
mi
from
Allen, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling, Phase
Updated: 12/31/1969
Providence & Providence Park Hospital
mi
from
Southfield, MI
Click here to add this to my saved trials
Pediatric Crohn's Disease Clinical Trial
Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Stanford Children's Health
mi
from
Alto, CA
Click here to add this to my saved trials
Pediatric Crohn's Disease Clinical Trial
Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Nemours Children's Health System - Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Pediatric Crohn's Disease Clinical Trial
Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Louis Children's Hospital at Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Adenoviral Conjunctivitis Clinical Trial
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Lake Travis Eye and Laser Center
mi
from
Lakeway, TX
Click here to add this to my saved trials
Adenoviral Conjunctivitis Clinical Trial
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Kentucky Eye Institute
mi
from
Lexington, KY
Click here to add this to my saved trials
Adenoviral Conjunctivitis Clinical Trial
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Senior Health Services
mi
from
Louisville, KY
Click here to add this to my saved trials
Adenoviral Conjunctivitis Clinical Trial
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Millenium Clinical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Adenoviral Conjunctivitis Clinical Trial
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Stanford Byers Eye Institute
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Adenoviral Conjunctivitis Clinical Trial
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Status: Enrolling, Phase III
Updated: 12/31/1969
Sacramento Eye Consultants
mi
from
Sacramento, CA
Click here to add this to my saved trials
Amyloidosis Clinical Trial
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis
Status: Enrolling, Phase III
Updated: 12/31/1969
Wake Forest University Health Sciences - Cardiovascular Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ
Status: Enrolling, Phase
Updated: 12/31/1969
Fundación de Hemofilia de Salta
mi
from
Salta,
Click here to add this to my saved trials
Critical Limb Ischemia (CLI) Clinical Trial
Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Miami Leonard M.Miller School of Medicine (UMMSM)-UHealth Pulmonary and Critical Care Medicine-Rosenstiel Building Location
mi
from
Miami, FL
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Adriana Pop-Moody MD Clinic PA /ID# 160009
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
C.V. Mehta MD, Medical Corporation /ID# 161192
mi
from
Hemet, CA
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Rheumatology Consultants, PLLC /ID# 161408
mi
from
Knoxville, TN
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Kotha and Kotha /ID# 159834
mi
from
La Mesa, CA
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Clinical Research /ID# 159922
mi
from
Meridian, ID
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinvest Research LLC /ID# 161208
mi
from
Springfield, MO
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Deerbrook Medical Associates /ID# 159815
mi
from
Vernon Hills, IL
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
PMG Research of Wilmington LLC /ID# 161403
mi
from
Wilmington, NC
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Clinical Trials /ID# 163435
mi
from
Chicago, IL
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
STAT Research, Inc. /ID# 161392
mi
from
Dayton, OH
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Omega Research Consultants, LLC /ID# 164193
mi
from
DeBary, FL
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
EmergeOrtho, P.A. /ID# 161391
mi
from
Durham, NC
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Rheumatology, PC /ID# 159893
mi
from
Lansing, MI
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Little Rock Diagnostics Clinic /ID# 165161
mi
from
Little Rock, AR
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Trinity Health Medical Arts Clinic /ID# 159800
mi
from
Minot, ND
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Westroads Clinical Research, Inc. /ID# 159979
mi
from
Omaha, NE
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Millennium Research /ID# 159822
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Source, Inc. /ID# 164545
mi
from
Perrysburg, OH
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Arthritis & Osteoporosis Clinic /ID# 159786
mi
from
Waco, TX
Click here to add this to my saved trials
Psoriatic Arthritis Clinical Trial
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
Status: Enrolling, Phase III
Updated: 12/31/1969
Medvin Clinical Research /ID# 160034
mi
from
Whittier, CA
Click here to add this to my saved trials
Bile Acid Synthesis Disorders Clinical Trial
The REPLACE Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Center for Digestive Health
mi
from
Atlanta, GA
Click here to add this to my saved trials
Zenker Diverticulum Clinical Trial
A New Treatment for Zenker's Diverticulum-submucosal Tunneling Endoscopic Septum Division
Status: Enrolling
Updated: 12/31/1969
NYU Winthrop Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD
Status: Enrolling, Phase II
Updated: 12/31/1969
Yale Nephrology Clinical Research
mi
from
New Haven, CT
Click here to add this to my saved trials
Nephrology / Urology Clinical Trial
Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKD
Status: Enrolling, Phase II
Updated: 12/31/1969
Baylor Scott & White Research Institute
mi
from
Temple, TX
Click here to add this to my saved trials
Musculoskeletal, Neurology, Psychiatry / Psychology, Orthopedics / Podiatry Clinical Trial
Immersive Virtual Reality for Neuropathic Pain
Status: Enrolling
Updated: 12/31/1969
Loma Linda University Health, East Campus Outpatient Rehabilitation Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
Status: Enrolling, Phase III
Updated: 12/31/1969
Urology Associates [Nashville, TN] ( Site 0063)
mi
from
Nashville, TN
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical Oncology Associates (Summit Cancer Centers) ( Site 0014)
mi
from
Spokane, WA
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
Status: Enrolling, Phase III
Updated: 12/31/1969
Oklahoma Cancer Specialists and Research Institute, LLC
mi
from
Tulsa, OK
Click here to add this to my saved trials
Hypogonadism, Male Clinical Trial
Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men
Status: Enrolling, Phase III
Updated: 12/31/1969
Rapha Institute For Clinical Research
mi
from
Fayetteville, NC
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Vaginitis Gardnerella Clinical Trial
Treatment of Gardnerella Vaginalis Vaginal Colonization With Amoxicillin
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Alabama at Birmingham School of Medicine- Infectious Disease
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
IHA Hematology Oncology Consultants-Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Cancer Care Center-Caldwell
mi
from
Caldwell, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Hematology Oncology Consultants-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Main Line Health Center-Exton
mi
from
Exton, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Medical Campus
mi
from
Macomb, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Macomb Township
mi
from
Macomb, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Fairview Maple Grove Medical Center
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Marshfield Medical Center-Rice Lake
mi
from
Rice Lake, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
PeaceHealth United General Medical Center
mi
from
Sedro-Woolley, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Southwest Illinois Health Services LLP
mi
from
Swansea, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Advanced Breast Care Center PLLC
mi
from
Warren, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Warren
mi
from
Warren, MI
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
San Jorge Children's Hospital
mi
from
San Juan,
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Johns Hopkins All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
San Jorge Children's Hospital
mi
from
San Juan,
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Continued Access Protocol for the Evaluation of the OPTIMIZER Smart System
Status: Enrolling
Updated: 12/31/1969
St. Mary Research Institute
mi
from
Langhorne, PA
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
Status: Enrolling, Phase
Updated: 12/31/1969
Memoral Sloan Kettering Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Thyroid Cancer Clinical Trial
RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials